LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

Lantheus Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$99.92+0.22 (+0.22%)

Close on Oct 19, 2026

Market cap: $6.75B
P/E (TTM): 24.2
Dividend yield: –

Lantheus Holdings, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Revenue	1,542	1,534	1,296	935	425	339	347	343	331	302	293	302	284
Cost of Revenue	600	546	587	353	238	201	173	168	169	164	158	176	206
Gross Profit	942	988	710	582	188	139	175	175	162	138	136	126	77
Research & Development	177	168	78	312	45	33	20	17	18	12	14	14	30
Selling, General & Admin	454	372	267	234	219	110	103	93	92	75	79	72	68
Selling & Marketing	179	178	142	100	68	41	42	43	42	37	35	35	35
General & Administrative	275	194	125	134	150	69	61	50	50	39	44	37	33
Advertising Expenses	16	30	26	26	18	5.20	3.80	4.00	4.40	3.60	3.10	2.80	2.70
Operating Expenses	–	–	–	–	–	143	123	110	110	–	93	86	96
Operating Income	311	457	365	36	-61	-4.20	52	64	52	57	43	39	-19
Interest Expense	20	20	20	7.19	7.75	9.48	14	17	18	27	39	42	43
Interest & Investment Income	23	37	20	2.61	0.05	0.24	0.69	0.17	0.02	–	0.02	0.03	0.10
Other Non-Operating Income	31	37	66	-1.70	-7.35	2.20	-6.22	2.47	8.64	0.22	-0.07	0.51	1.16
Merger & Restructuring Charges	12	9.40	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	138	0	9.73	0	0	0	0	0	–	–	–
Gain (Loss) on Investments	-8.62	-44	0	0	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0	8.42	0	0	15	-2.25	-0.29	-0.84	–	–	–	–	–
Legal Settlements	–	0	0	5.49	0	0	3.45	0	0	–	–	–	8.88
Pretax Income	314	431	411	27	-75	-11	29	50	40	28	-12	-2.37	-61
Income Tax Expense	80	119	84	-1.35	-3.76	1.99	-3.04	9.03	-84	1.53	2.97	1.20	1.01
Net Income	234	312	327	28	-71	-13	32	41	123	–	–	–	–
Net Income to Common	234	312	327	28	-71	–	–	41	123	27	-15	-3.56	-62
EPS (Basic)(per share)	3.46	4.52	4.79	0.41	-1.06	-0.25	0.81	1.06	3.31	0.84	-0.60	-0.20	-3.42
EPS (Diluted)(per share)	3.41	4.36	4.65	0.40	-1.06	-0.25	0.79	1.03	3.17	0.82	-0.60	-0.20	-3.42
Shares Outstanding (Basic, Weighted)(shares)	67	69	68	68	67	54	39	38	37	32	24	18	18,032
Shares Outstanding (Diluted, Weighted)(shares)	68	72	70	71	67	54	40	40	39	33	24	18	18,032
EBITDA	381	522	425	84	-19	20	65	78	71	75	62	58	6.89

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 60.1%
Operating margin: 19.4%
Net margin: 17.7%
Return on equity, FY2025: 21.4%

Financial strength

Current ratio: 3.06
Debt to equity: 0.44
Debt to assets: 23.6%
Cash to current liabilities: 176.7%

Valuation

P/E ratio: 24.2
Price to sales: 4.33
Price to book: 5.14
Dividend yield: –